LAPIX Therapeutics Inc. Announces First Subjects Dosed in its First-in-Human Clinical Study of its Treg-expanding Tim3/4 Agonist LPX-TI641 to Treat Multiple Sclerosis and other Autoimmune Conditions

2 years ago

BOSTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- LAPIX Therapeutics, Inc. (“LAPIX”), a biopharmaceutical company focused on developing novel, orally bioavailable…

Glow Lifetech Announces New Product Listings from Ontario Cannabis Store; Expanding MOD Drops Portfolio and First Shipment of .decimal Capsules

2 years ago

Toronto, Ontario--(Newsfile Corp. - November 7, 2023) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the…

CBD of Denver Inc. Announces Significant Advancements in European Operations by Luxora Team

2 years ago

Denver, Colorado--(Newsfile Corp. - November 7, 2023) - Last week, the CBD of Denver, Inc.'s (OTC Pink: CBDD), Luxora team…

FendX to Conduct Second Pilot Run on Dunmore’s Commercial Manufacturing Line for Further Development of REPELWRAP(TM) Film

2 years ago

Oakville, Ontario--(Newsfile Corp. - November 7, 2023) - FendX Technologies Inc. (CSE:FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX")…

Dr. Gail Naughton, World-Renowned Authority in the Multibillion-Dollar Regenerative Medicine Market, Joins HippoFi as the Head of Regenerative Therapeutics and Commercialization

2 years ago

Scientist, inventor, business expert, and holder of more than 140 patents will bring forward PUR Biologics' regenerative therapeutic patent portfolio…

Nemysis Limited Receives EU Horizon Grant Funding for E40

2 years ago

DUBLIN, IRELAND / ACCESSWIRE / November 7, 2023 / Nemysis is pleased to announce receipt of grant funding under the…

Defence Therapeutics Key Platform Patent Accepted Broadly Covering Vaccine Technology

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - November 7, 2023) -  Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or…

Nomination Committee Appointed for IRLAB’s Annual General Meeting 2024

2 years ago

GOTHENBURG, SE / ACCESSWIRE / November 07, 2023 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, November 7, 2023 - IRLAB…

Hecla Reports Third Quarter 2023 Results

2 years ago

For The Period Ended: September 30, 2023COEUR D'ALENE, Idaho--(BUSINESS WIRE)--Hecla Mining Company (NYSE:HL) today announced third quarter 2023 operating and…